Arnold Daas
Impact in
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Endocrinology top 10%
- Diphtheria, Corynebacterium, and Tetanus
Papers in
-
- Analytical Methods in Pharmaceuticals 16
-
- Diphtheria, Corynebacterium, and Tetanus 9
- Co-authors
- Dorothea Sesardic (7 shared papers)Randi Winsnes (4 shared papers)K H Buchheit (9 shared papers)R. A. Maas (2 shared papers)Ivo J. T. M. Claassen (2 shared papers)Janet M. Daly (1 shared paper)Richard A. Isbrucker (1 shared paper)Coenraad F. M. Hendriksen (2 shared papers)
- Journals
- Biologicals (2 papers)Allergy (1 paper)Vox Sanguinis (1 paper)PubMed (51 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
Arnold Daas
54 papers receiving 362 citations
Peers
Comparison fields: 5 of 46
- Immunology and Allergy 63
- Endocrinology 45
- Virology 44
- Microbiology 60
- Small Animals 80
Countries citing papers authored by Arnold Daas
This map shows the geographic impact of Arnold Daas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Daas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Daas more than expected).
Fields of papers citing papers by Arnold Daas
This network shows the impact of papers produced by Arnold Daas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Daas. The network helps show where Arnold Daas may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnold Daas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. | 2010 | 35 |
| 2 | Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies. | 2012 | 34 |
| 3 | 2016 | 24 | |
| 4 | Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2). | 2004 | 22 |
| 5 | Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. | 2004 | 21 |
| 6 | Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use. | 1999 | 20 |
| 7 | Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines. | 2010 | 17 |
| 8 | Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study. | 2011 | 17 |
| 9 | Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparation. | 2007 | 15 |
| 10 | Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines. | 2016 | 15 |
| 11 | Establishment of European pharmacopoeia Mycoplasma reference strains. | 2006 | 13 |
| 12 | 2013 | 11 | |
| 13 | Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay. | 2002 | 10 |
| 14 | Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin. | 2003 | 10 |
| 15 | Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. | 2015 | 10 |
| 16 | Validation of ELISA methods for quantification of the major birch allergen Bet v 1 (BSP090). | 2017 | 10 |
| 17 | A Vero cell method for potency testing of diphtheria vaccines. | 2002 | 9 |
| 18 | Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique. | 2004 | 9 |
| 19 | Collaborative study for the establishment of erythropoietin BRP batch 3. | 2007 | 9 |
| 20 | Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use. | 2004 | 8 |
About Arnold Daas
Arnold Daas is a scholar working on Analytical Chemistry, Endocrinology, Immunology, Statistics, Probability and Uncertainty and Microbiology, having authored 56 papers that have together received 412 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (16 papers), Biosimilars and Bioanalytical Methods (15 papers), Diphtheria, Corynebacterium, and Tetanus (9 papers), Scientific Measurement and Uncertainty Evaluation (7 papers), Bacterial Infections and Vaccines (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Clinical Laboratory Practices and Quality Control (4 papers). The work is most often cited by research in Immunology and Allergy (63 citations), Endocrinology (45 citations), Virology (44 citations), Microbiology (60 citations) and Small Animals (80 citations). Arnold Daas has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Dorothea Sesardic, Randi Winsnes, K H Buchheit, R. A. Maas, Ivo J. T. M. Claassen, Janet M. Daly, Richard A. Isbrucker, Coenraad F. M. Hendriksen, Adrian F. Bristow and D. Xing. Their work appears in journals such as Biologicals, Allergy, Vox Sanguinis and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.